BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--VS-7375 (investigational KRAS G12D ON/OFF inhibitor) demonstrates clinical activity with a favorable safety profile in TARGET-D 101 clinical trial.

Versus Systems Inc. (VS) stock price & volume — 10-year historical chart
Investment Thesis • Updated 2026Q1
the company's precarious liquidity position, evidenced by a cash balance of only $527,388 against a history of significant quarterly cash burn, suggests an imminent risk of further shareholder dilution.
Versus Systems Inc. (VS) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Versus Systems Inc. (VS) EPS & revenue vs analyst estimates — last 4 quarters
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | May 15, 2026 | $0.14 | $17,300 |
| Q2 2026 | Apr 15, 2026 | $0.27 | $5,580 |
| Q4 2025 | Nov 14, 2025 | $0.11 | — |
| Q3 2025 | Aug 14, 2025 | $0.14 | $2M |
Recent stock market news and headlines for Versus Systems Inc. (VS)
BOSTON--(BUSINESS WIRE)---- $VSTM #CRC--VS-7375 (investigational KRAS G12D ON/OFF inhibitor) demonstrates clinical activity with a favorable safety profile in TARGET-D 101 clinical trial.

Key metrics vs top competitors for Versus Systems Inc. (VS)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $1.59 | $7.77M | -4.28 | 3713.89% | -82.08% | -51.47% | — | |
| $8.84 | $137.97M | -1.96 | 9.46% | -59.74% | -55.16% | — | |
| $0.39 | $8.55M | -1.30 | -3.07% | -17.49% | -40.41% | — | |
| $0.66 | $85.2M | -2.89 | -18.77% | -15.79% | -15.65% | — | |
| $26.91 | $13.34B | -3322.22 | 26.99% | 0.93% | 7.88% | — | |
| $20.78 | $2.78B | -3.56 | 5.82% | -13.54% | -44.61% | — |
Versus Systems Inc. (VS) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Versus Systems Inc. (VS) SEC filings — annual & quarterly reports (10-K, 10-Q)
May 5, 2026·SEC
Apr 16, 2026·SEC
Mar 3, 2026·SEC
Get notified when VS posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
Versus Systems Inc. (VS) stock FAQ — growth, dividends, profitability & financials explained
Versus Systems Inc. (VS) reported $2.0M in revenue for fiscal year 2025. This represents a 11278% increase from $0.0M in 2000.
Versus Systems Inc. (VS) grew revenue by 3713.9% over the past year. This is strong growth.
Versus Systems Inc. (VS) reported a net loss of $2.1M for fiscal year 2025.
Versus Systems Inc. (VS) has a return on equity (ROE) of -51.5%. Negative ROE indicates the company is unprofitable.
Versus Systems Inc. (VS) had negative free cash flow of $1.6M in fiscal year 2025, likely due to heavy capital investments.